In this Section |
218194 Identification of Factors Associated with Prescription Opioid Overdose Death Through Next-of-Kin InterviewsTuesday, November 9, 2010
: 11:10 AM - 11:30 AM
Background: Prescription opioid deaths in Utah increased by >500% during 1999–2007. Knowledge is limited regarding associated factors. Understanding characteristics of prescription opioid decedents can guide prevention. Methods: During October 2008–August 2009, drug overdose decedents were identified from medical examiner records and next-of-kin interviewed. We focused on unintentional or intent-undetermined deaths where a prescription opioid, but not an illicit drug, was causally implicated. History of substance abuse, mental illness, and prescriptions were assessed. Substance abuse history was defined as ever using heroin, cocaine, hallucinogens, or methamphetamine, or ever receiving substance abuse treatment. Mental illness history was defined as having a chronic mental illness, diagnosis of mental illness by a provider, or nondrug-related psychiatric hospitalization. Results: Of 155 prescription opioid overdose decedents, 82 (53%) were female. Median age of females (46 years) was higher than males (32 years) (P<.0001). Substance abuse history was reported for 93 (60%) decedents, prior heroin use for 31 (20%), and mental illness history for 89 (57%). Overall, 124 (80%) reportedly had used their own prescribed pain medication during their last year. Use of prescribed pain medication during their last year was common for decedents with history of substance abuse (n=75; 81%), heroin use (n=22; 71%), and mental illness (n=70; 79%). Conclusions: The majority of prescription-opioid–overdose decedents in Utah had a history of substance abuse or mental illness. The majority used prescribed pain medication during their last year. Providers should use caution when prescribing opioids to patients with history of substance abuse or mental illness.
Learning Areas:
EpidemiologyPublic health or related research Learning Objectives:
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I contributed to the design and analysis of this project. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4072.0: Prescription Drug Misuse: Predictors, Measuring & Related Factors
|